A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference91 articles.
1. Inflammatory Bowel Disease;SB Hanauer;New England Journal of Medicine,1996
2. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management;A Dignass;J Crohns Colitis,2010
3. Cost Effectiveness of Treatments for Inflammatory Bowel Disease;K Bodger;Pharmacoeconomics,2011
4. Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty;SB Hanauer;Nat Clin Pract Gastroenterol Hepatol,2005
5. Crohn's disease;J Torres;The Lancet,2017
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease;Arab Journal of Gastroenterology;2024-08
2. Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study;Inflammatory Bowel Diseases;2024-04-26
3. High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease;European Journal of Clinical Pharmacology;2024-03-30
4. Transitioning patients from intravenous to subcutaneous infliximab and vedolizumab for inflammatory bowel disease: what is the opportunity cost of improving access to healthcare?;Internal Medicine Journal;2024-01-12
5. ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?;Arquivos de Gastroenterologia;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3